Cross-Reactive Medications in Alpha-Gal Syndrome

Cross Reactive Medications — scientific infographic poster

Table of Contents

  1. Why This Matters More Than You’d Expect
  2. Cetuximab
  3. Heparin and Related Anticoagulants
  4. Porcine Pancreatic Enzymes
  5. Insulin — Historical and Current
  6. Vaccines Containing Gelatin
  7. Capsule Shells
  8. Magnesium Stearate — The Debate
  9. Surgical & Procedural Exposures
  10. Anesthesia Considerations
  11. Radiocontrast Dyes
  12. Dental & Wound Care
  13. Everyday Supplements & Over-the-Counter
  14. The Pre-Procedure Wallet Card / Action Letter
  15. Pre-Medication Protocols for Unavoidable Exposures
  16. Key Research Papers
  17. Connections
  18. Featured Videos

1. Why This Matters More Than You’d Expect

Most Alpha-Gal Syndrome (AGS) patients focus hard on food labels and restaurant menus, and then get blindsided in a hospital. Medications and medical products can contain far more alpha-gal per gram than a ribeye steak, and many are delivered intravenously or by injection — bypassing the stomach entirely.

That matters because digestion is what slows food-borne alpha-gal reactions down. Eat beef and you react 3–6 hours later. Infuse a mammalian-derived drug and you can be in anaphylaxis within minutes, often during the first dose.

Your primary care doctor, your pharmacist, and the anesthesia team prepping you for surgery may have never heard of alpha-gal. This page lists the medicines and medical products that contain mammalian material, the reactions reported with them, and the options with no mammalian content.

A 2020 review by Platts-Mills and colleagues puts the risk in proportion: products such as heart valves, gelatin-based plasma expanders and pancreatic enzymes “are relevant to only select patient groups”, and only “a minority of cases may benefit from avoiding a wide range of products” made with mammalian ingredients such as gelatin. The review describes avoiding mammalian meat, and dairy in some cases, as the primary treatment.

2. Cetuximab

Cetuximab is the monoclonal antibody that accidentally discovered alpha-gal. In 2008, Chung (Vanderbilt University), Platts-Mills (University of Virginia) and colleagues published the landmark paper in the New England Journal of Medicine showing that patients in the Southeastern US (treated mainly in Tennessee, Arkansas and North Carolina) were suffering first-dose anaphylaxis to cetuximab — and that their pre-existing immunoglobulin E (IgE) targeted a sugar on the drug, not the protein.

Why cetuximab is so dangerous in AGS

Alternative

Panitumumab is a human monoclonal antibody that its US label says is produced in genetically engineered Chinese hamster ovary cells, and it does not carry alpha-gal. The 2020 Platts-Mills review links cetuximab’s alpha-gal to the mouse SP2/0 cells it is made in, noting that most other monoclonal antibodies are made in other cell lines, such as Chinese hamster ovary cells. Panitumumab also targets the epidermal growth factor receptor (EGFR) and is the EGFR-targeted alternative described for AGS patients.

3. Heparin and Related Anticoagulants

Heparin is the single most common intraoperative exposure. It is extracted from porcine intestinal mucosa (pork) and, historically, bovine lung. It is glycosaminoglycan-rich and can carry alpha-gal contamination.

Porcine-derived heparins

Anticoagulants with no mammalian content

Before any major procedure, a written note to the anesthesia and surgical team is how a heparin-free protocol gets planned. Bivalirudin and fondaparinux are among the alternative anticoagulants when heparin is contraindicated.

Published case reports also describe heparin itself being given to people with alpha-gal syndrome. A 2022 case report describes heparin desensitization before heart-lung bypass in a patient with confirmed alpha-gal allergy (McRae 2022). A 2024 case report describes a 31-year-old man with alpha-gal syndrome who had no adverse reaction to heparin products during heart surgery (Taira 2024). A 2026 case series describes three people with documented alpha-gal syndrome who had transcatheter aortic valve replacement; two received no drug pre-treatment, and heparin given during the procedure caused no reactions in any of them (Lari 2026).

How often heparin itself causes reactions is still being studied. One heart-surgery center reviewed 8,819 cardiac operations from 2007 to 2019 (Hawkins 2021). Seventeen patients had a positive alpha-gal blood test before surgery; 4 of them (24%) had a severe allergic reaction during the high-dose intravenous heparin given for heart-lung bypass, as did 4 of the 8 (50%) who had a recent alpha-gal IgE result. Patients who reacted had much higher alpha-gal antibody levels (median 75 IU/mL against 8 IU/mL), while heparin doses did not differ between those who reacted and those who did not. The authors recommend checking alpha-gal IgE and premedicating before high-dose intravenous heparin when alpha-gal syndrome is suspected.

4. Porcine Pancreatic Enzymes

Pancreatic enzyme replacement therapy (PERT) for chronic pancreatitis, cystic fibrosis, or post-Whipple pancreatic insufficiency is almost universally porcine-derived.

Porcine enzyme products

There is no widely available non-mammalian PERT product on the US market. Some AGS patients tolerate these enzymes and others react strongly; why is not known. Researchers write that “the amount of alpha-gal that is absorbed from oral medications containing mammalian ingredients is currently unknown”. In the published cases below, first doses were given under observation in an allergy clinic.

In a 2020 report, two alpha-gal patients whose skin tests to porcine pancreatic enzymes were positive took the enzymes by mouth under observation in an allergy clinic. The first, who was taking an antihistamine twice daily, had only itching without a rash and then took the enzyme capsules three times a day with meals through 6 months of follow-up. The second first took the capsule contents mixed in water, without the capsule shell, and after pancreatic surgery built up to full capsules with every meal, still tolerated 8 months later. In these two people a positive skin test alone did not predict a reaction (Stone 2020).

5. Insulin — Historical and Current

Historical: Before the 1980s, insulin was extracted from bovine and porcine pancreas. Those products are no longer used in developed markets.

Current insulins contain no mammalian material. All modern human insulin and insulin analogs — lispro, aspart, glargine, detemir, degludec — are recombinant products made in yeast or E. coli, according to their US labels. No mammalian cells, no alpha-gal.

6. Vaccines Containing Gelatin

Gelatin is a common vaccine stabilizer, especially in live attenuated products. The US label of the measles-mumps-rubella (MMR) vaccine lists 14.5 mg of hydrolyzed gelatin per dose. In a 2017 case report, a patient with alpha-gal allergy had anaphylaxis after a zoster (shingles) vaccine; testing then found alpha-gal in the MMR and zoster vaccines, which share a higher gelatin content and contain bovine calf serum (Stone 2017).

Gelatin-containing vaccines

Vaccines without gelatin

If an AGS patient needs a gelatin-containing vaccine (pregnancy planning and MMR, travel and yellow fever), allergists describe pre-medication plus a graded-dose protocol in the office, with epinephrine on hand, as the way most such patients receive it.

7. Capsule Shells

Most hard-shell and soft-gel capsules are made of porcine or bovine gelatin. The active drug inside may be completely synthetic, but the shell alone can provoke reactions.

Options with no mammalian content

Compounding pharmacies can re-encapsulate almost any drug in HPMC shells for a modest fee. A prescription note reading “dispense in non-gelatin capsule” is how this is requested, and most insurance will still cover it.

8. Magnesium Stearate — The Debate

Magnesium stearate is the most common tablet-flow agent in the industry. The stearic acid can come from vegetable sources (palm, soy, coconut) or from beef tallow. The label almost never says which.

Here is the honest answer: most AGS patients tolerate magnesium stearate regardless of source. The amounts are milligram-scale, the molecule is a fatty acid salt (not intact protein or intact glycolipid), and the processing denatures most of the alpha-gal structure.

High-titer, highly reactive patients on a daily maintenance medication sometimes ask the manufacturer for a source-of-stearate letter, and many manufacturers provide one on request. Some supplement makers label “vegetable stearate” explicitly.

9. Surgical & Procedural Exposures

Surgery is where AGS gets dangerous fast. A written list of every product below, given to the surgeon and anesthesiologist about two weeks before the operation, gives the team time to plan alternatives.

Products made with mammalian material

Options with no mammalian content

10. Anesthesia Considerations

Most anesthesia drugs are fully synthetic. The risks are in the adjuncts.

No mammalian content

Adjuncts to know about

11. Radiocontrast Dyes

Most iodinated contrast agents (iohexol, iopamidol, iodixanol) used in computed tomography (CT) and angiography are fully synthetic iodine-based molecules with no alpha-gal.

Gadolinium-based contrast for magnetic resonance imaging (MRI) is also synthetic and generally free of mammalian material, although carrier molecules and preservatives differ between products.

Classical radiocontrast hypersensitivity (a non-IgE pseudoallergy with its own pre-medication protocol) is a different mechanism from alpha-gal reactivity, with a different workup.

12. Dental & Wound Care

Dentists rarely think about alpha-gal; the wallet card below covers dental products too.

13. Everyday Supplements & Over-the-Counter

Many supplements contain mammalian ingredients, and labels often do not state the source.

14. The Pre-Procedure Wallet Card / Action Letter

The text below is an example of a pre-procedure wallet card or letter, written in the patient’s own voice, of the kind patients carry and hand to doctors, dentists and surgeons.

I have Alpha-Gal Syndrome — an immunoglobulin E-mediated allergy to galactose-α-1,3-galactose, a carbohydrate present in all non-primate mammals.

I react to products containing mammalian material, including: heparin and low-molecular-weight heparins (fondaparinux or a DOAC are alternatives); porcine pancreatic enzymes; bovine and porcine gelatin (hemostatic agents, vaccine stabilizers, capsule shells); bovine and porcine heart valves; bovine-derived hyaluronic acid; catgut sutures; gelatin-containing intravenous volume expanders; collagen injections and grafts.

Alternatives without mammalian content exist for most items above.

Pre-medication protocol (per my allergist): prednisone 40–60 mg at 13, 7, and 1 hour before procedure; cetirizine 10 mg and famotidine 20 mg one hour before; intravenous diphenhydramine 50 mg and hydrocortisone 100 mg available; epinephrine auto-injector at bedside.

My allergist: [name, phone]. In anaphylaxis: 0.3 mg IM epinephrine, call 911, transport.

Pre-printed cards are available from Alpha-Gal Information (alphagalinformation.org) and the Virginia Tech Center for Food Animal Health.

15. Pre-Medication Protocols for Unavoidable Exposures

When an AGS patient absolutely needs a mammalian-derived product (a heparin-free surgical plan impossible; a gelatin-containing vaccine mandatory for travel), the standard allergy-desensitization framework applies.

Standard pre-medication

Procedure-day setup

This is the same framework used for cetuximab desensitization and taxane hypersensitivity. It works for the majority of unavoidable AGS exposures.

Key Research Papers

  1. Chung CH, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-α-1,3-galactose. N Engl J Med. 2008;358(11):1109–1117. — doi:10.1056/NEJMoa074943
  2. Dunkman WJ, Rycek W, Manning MW. What does a red meat allergy have to do with anesthesia? Perioperative management of alpha-gal syndrome. Anesth Analg. 2019;129(5):1242–1248. — PubMed PMID: 29847378
  3. Platts-Mills TAE, Li RC, Keshavarz B, Smith AR, Wilson JM. Diagnosis and management of patients with the α-Gal syndrome. J Allergy Clin Immunol Pract. 2020;8(1):15–23.e1. — doi:10.1016/j.jaip.2019.09.017
  4. Stone CA Jr, Hemler JA, Commins SP, Schuyler AJ, Phillips EJ, Peebles RS Jr, Fahrenholz JM. Anaphylaxis after zoster vaccine: implicating alpha-gal allergy as a possible mechanism. J Allergy Clin Immunol. 2017;139(5):1710–1713.e2. — PubMed PMID: 27986511
  5. Stone CA Jr, Choudhary S, Patterson MF, Rukasin CRF, Coleman DT, Phillips EJ, Commins SP. Tolerance of porcine pancreatic enzymes despite positive skin testing in alpha-gal allergy. J Allergy Clin Immunol Pract. 2020;8(5):1728–1732.e1. — PubMed PMID: 31846796
  6. Hawkins RB, Wilson JM, Mehaffey JH, Platts-Mills TAE, Ailawadi G. Safety of intravenous heparin for cardiac surgery in patients with alpha-gal syndrome. Ann Thorac Surg. 2021;111(6):1991–1997. — PubMed PMID: 33031779
  7. Colli A, Zilla P, Calafiore AM, et al. Quantification of alpha-gal expression in commercial bioprosthetic heart valves and its potential mitigation. Struct Heart. 2026;10(3):100739. — PubMed PMID: 41646629
  8. Aykut B, Lim HK, Ngeve SM, et al. Perioperative outcomes after bioprosthetic valve replacement in patients sensitized to alpha-gal. Ann Thorac Surg Short Rep. 2025;3(1):264–268. — PubMed PMID: 40098868
  9. McRae AS, Tidwell WP, Patel S, Lombard FW. Heparin desensitisation prior to cardiopulmonary bypass in a patient with alpha-gal allergy. Anaesth Rep. 2022;10(2):e12203. — PubMed PMID: 36561536
  10. Taira K, Kanade R, Yammine M, Tannous H, Kumar S. Alpha gal syndrome, a relative not absolute contraindication to the use of bovine pericardium to close an intracardiac septal defect: a case report. J Cardiothorac Surg. 2024;19(1):221. — PubMed PMID: 38627833
  11. Lari K, Leghari S, Smeltz AM, Patel D, Teeter EG. Alpha-Gal Syndrome-A Case Series of Successful Transcatheter Mammalian-Derived Aortic Valve Replacements. Semin Cardiothorac Vasc Anesth. 2026;30(3):216–220. — PubMed PMID: 42375124
  12. Dang Van S, Fouquet O, Jeanneteau A, Leclere JM, Baufreton C. Aortic homograft for aortic valve replacement in patient with Alpha-Gal allergy. Gen Thorac Cardiovasc Surg. 2021;69(11):1499–1501. — PubMed PMID: 34279773

PubMed Topic Searches

Open literature searches on PubMed:

  1. PubMed: Alpha-gal + heparin
  2. PubMed: Alpha-gal + vaccine gelatin
  3. PubMed: Alpha-gal + perioperative
  4. PubMed: Cetuximab + anaphylaxis
  5. PubMed: Alpha-gal + bovine heart valve
  6. PubMed: Alpha-gal + magnesium stearate
  7. PubMed: Alpha-gal + pancreatic enzyme
  8. PubMed: Alpha-gal + drug reaction

Back to Table of Contents

Connections

Back to Table of Contents